5 Things To Know About Trump’s Medicaid Block Grant Plan
Federal officials unveiled guidance for states that want to opt out of some of the current funding program and instead seek a fixed payment to gain more flexibility.
The independent source for health policy research, polling, and news.
981-1,000 of 2,002 results
Federal officials unveiled guidance for states that want to opt out of some of the current funding program and instead seek a fixed payment to gain more flexibility.
After the state legalized recreational marijuana in 2016, new taxes and regulations decimated an ad hoc network that had donated cannabis for medical purposes to patients who could not afford it. A recent law seeks to revive the network, but hurdles remain.
Introducing a new segment on “An Arm and a Leg” podcast: “Can They Freaking Do That?!?” We take your most vexing medical bill questions and hunt down information and experts who can help.
Years ago, doctors sometimes lied about whose sperm they used for artificial inseminations. Could it happen now? Some argue regulation is weak in the multibillion-dollar fertility treatment industry.
Insurers' study points to the need for limits on out-of-network billing by doctors and hospitals. The American Medical Association calls the report "grossly misleading."
Neil Mahoney had terminal cancer. He also had a legal right to aid-in-dying. But his faith-based hospital called it “morally unacceptable.” So he turned to a network of Colorado doctors to fulfill his last wish.
A study finds that higher charges are associated with greater payments by private insurers, which can drive up costs for employers and consumers who pay their way.
The impact of the Trump administration’s health policies is not as clear-cut as the president’s reelection campaign suggests.
Private insurance plans vary in coverage for compression garments, and some fall short of meeting patients’ needs. Although Medicaid programs cover some of these expenses, Medicare does not.
The notion of a national program to tend to the day-to-day needs of a booming older population has circulated for years. Now, there are grants ― and grit ― behind it.
Members of Congress and others complain Medicare’s revamped Plan Finder had problems. Federal officials say they can help consumers who got bad information change their plans next year. But details about how switching will work are yet to come.
State regulators and even one medevac company have raised doubts about prepaid subscriptions and promised benefits offered by air ambulance companies.
The court, based in New Orleans, agreed with a federal judge in Texas that the individual mandate section of the Affordable Care Act could not stand after Congress eliminated the tax penalty for not having coverage. But the case now heads back to the lower court to see how much of the law can remain.
Some of the numbers cited by the Minnesota senator during Wednesday's Democratic presidential debate miss the mark.
The program, which will roll out next year in three parts of the country, seeks to encourage workers on the company’s health plan to choose doctors that have been identified as providing “appropriate, effective and cost-efficient care.”
As states and communities ban the sale of flavored tobacco products linked to vaping, anti-smoking activists are piggybacking on the momentum to target menthol cigarettes. But some African Americans say menthol cigarette bans will lead to discrimination.
The calming techniques that officers learn during training to intervene in a mental health crisis don't seem to work as well when a suspect is high on meth. Meth calls can be much more dangerous, police say.
Without the teamwork, communication and quick action of several veteran health officials in Wisconsin, the world might not know about the vaping illness the U.S. is battling today. This is their story.
“Lost on the Frontline” is an ongoing project by Kaiser Health News and The Guardian that aims to document the lives of health care workers in the U.S. who died from COVID 19, and to investigate why so many are victims of the disease.
Surgeon General Jerome Adams said the drug has a “unique impact” on the developing brain — technically true, but neglecting a vital comparison to other drugs, as well as shortcomings in the existing research.
© 2026 KFF